Journal profile · Medicine
Current Diabetes Reports
ISSN 1534-4827 · eISSN 1539-0829 · Springer US · US · Bimonthly · Founded 2001
Current Diabetes Reports: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 7.21; hybrid open access; APC about USD 4,890; median 92 days to acceptance (29 articles, last 24 months); 44 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Diabetes Reports is published by Springer US and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Pancreatic function and diabetes and Diabetes and associated disorders, together about 35.3% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of diabetes epidemiology, pathophysiology, and management. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators. We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.
From the journal's Aims & Scope
Editor-in-chief Roopa MehtaPublisher website
Editorial board by country: none in mainland China; most named United States 12, India 3, Canada 2, Austria 2, Greece 2 (30 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Management and ResearchMedicine15.2%
- Pancreatic function and diabetesMedicine10.7%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology9.4%
- Diabetes Treatment and ManagementMedicine8.2%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine6%
- Diet and metabolism studiesMedicine5%
- Diabetes Management and EducationMedicine4.7%
- Gestational Diabetes Research and ManagementMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.21LetPub ·
- Impact factor (publisher) 2025
- 7.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 7.1Publisher website ·
- CiteScore 2026-06
- 12.2LetPub ·
- SJR 2026-06
- 2.58LetPub ·
- SNIP 2026-06
- 2.54LetPub ·
- h-index
- 65LetPub ·
- h-index
- 139OpenAlex ·
- i10-index
- 1,658OpenAlex ·
- 2-year mean citedness
- 7.21OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 38.05%LetPub ·
Volume
- Articles per year
- 46LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 723,500Publisher website ·
Articles by year OpenAlex count · 2,269 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 32 | 22 | 36 |
| 2025 | 44 | 22 | 261 |
| 2024 | 38 | 19 | 525 |
| 2023 | 35 | 22 | 814 |
| 2022 | 55 | 36 | 1,968 |
| 2021 | 69 | 33 | 2,501 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
92 daysMedian, submission to acceptance · P25–P75 62 days – 167 days
- Acceptance to online
- median 20 days (85 articles)
- Submission to online
- median 133 days
- Sample
- 29 articles with submission and acceptance dates (96 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- Peer review
- Double anonymous peer review, Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,890 / EUR 3,890 / GBP 3,090 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted3
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. Editorial Procedure—additional information This journal adheres to a standard …Length not stated
- invited commentariesTypes for papers Reviews and Invited CommentariesLength not stated
- reviewsTypes for papers Reviews and Invited CommentariesLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Current Diabetes Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- US
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2001
- ISSN
- 1534-4827
- Electronic ISSN
- 1539-0829
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Diabetes Reports
What CAS zone is Current Diabetes Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Diabetes Reports is in Zone 2 of Medicine, and in Zone 2 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Diabetes Reports?
The latest impact factor listed by LetPub is 7.21; CiteScore 12.2, h-index 139.
How long does peer review take at Current Diabetes Reports?
Based on the dates recorded on 29 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 92 days (interquartile range 62–167 days); authors report an average review time of 6–12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Diabetes Reports?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Diabetes Reports based?
Of the 30 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (12), India (3) and Canada (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Diabetes Reports?
According to LetPub and DOAJ records, Current Diabetes Reports is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Current Diabetes Reports open access, and what is the APC?
Current Diabetes Reports is a hybrid journal. For open-access publication: APC about USD 4,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .